Pharmaceutical outsourcing to CROs is certainly nothing new. However, this week we learned that pharmaceutical giant Lilly and AMRI signed an interesting insourcing / outsourcing agreement. In this deal, AMRI…
Lacerta Bio spent the week at the AAPS ( American Association of Pharmaceutical Scientists ) annual conference . Over 8,000 pharmaceutical scientists, service providers, and others came to AAPS in…
Call us late to the party, but in August of this year, KPMG published Future Pharma: Five Strategies to Accelerate the Transformation of Pharmaceutical Industry... The entire report is available…
In our view, there are two basic types of biotech business development-related due diligence. The first is external , where the team gathers and analyzes data about a target company…
In a few weeks, Lacerta Bio will return to DC to participate in the annual convention and celebrate the 25th anniversary of the American Association of Pharmaceutical Scientists (AAPS). AAPS…
Some members of the media are ebullient with the news that Merck is "getting into venture capital." However, as In Vivo is reporting, Merck is undertaking two initiatives that are…
Yesterday's Financial Times reported that pharmacists in Spain are struggling to continue operating their businesses due to a lack of payment from the Regional governments. “We depend 80 to 90…
As FiercePharma correctly points out, GSK's Q II report reflects the overall industry trends quite accurately: The rest of Glaxo's report, like the rest of Big Pharma's Q2 results so…
Luke Timmerman at Xconomy wrote a provocative piece today entitled The Missing Ingredient in Today's Biotech: Guts. His thesis is that the industry is so paralyzed by fear and insecurity that it lacks…
The pharmaceutical industry has benefitted mankind by developing life-saving and life-sustaining drugs. However, recent turmoils have led many to question the value provided by the industry. Matt Herper tackles these complex issues across two blog posts.